Teva Taps Board Member Elstein For Biogenerics VP Post
This article was originally published in The Pink Sheet Daily
Executive Summary
The appointment could reflect a significant push toward the development of follow-on biologics. The generic firm announces several personnel changes, including promotions of its top North America officers.